JP5455292B2 - Skin external composition - Google Patents
Skin external composition Download PDFInfo
- Publication number
- JP5455292B2 JP5455292B2 JP2007159474A JP2007159474A JP5455292B2 JP 5455292 B2 JP5455292 B2 JP 5455292B2 JP 2007159474 A JP2007159474 A JP 2007159474A JP 2007159474 A JP2007159474 A JP 2007159474A JP 5455292 B2 JP5455292 B2 JP 5455292B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- ceramide
- composition
- amino acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 62
- 229940106189 ceramide Drugs 0.000 claims description 66
- 150000001413 amino acids Chemical class 0.000 claims description 61
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 60
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 60
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 60
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 60
- 239000002537 cosmetic Substances 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 description 62
- 229940024606 amino acid Drugs 0.000 description 62
- 230000005068 transpiration Effects 0.000 description 50
- 102000011782 Keratins Human genes 0.000 description 45
- 108010076876 Keratins Proteins 0.000 description 45
- 230000014759 maintenance of location Effects 0.000 description 39
- 210000003491 skin Anatomy 0.000 description 38
- 230000001629 suppression Effects 0.000 description 27
- 230000000694 effects Effects 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- -1 phytosphingosine Chemical compound 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 150000001783 ceramides Chemical class 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 4
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 4
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013930 proline Nutrition 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002781 deodorant agent Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 235000008521 threonine Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000000118 hair dye Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 240000005926 Hamelia patens Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、皮膚外用組成物に関する。より詳細には、本発明は、高い水分保持効果及び水分蒸散抑制効果を示す皮膚外用組成物に関する。 The present invention relates to an external composition for skin. More specifically, the present invention relates to an external composition for skin showing a high moisture retention effect and moisture transpiration suppression effect.
外部刺激、乾燥等の影響を受けやすい乾燥性敏感肌を有する人にとって、化粧品等を用いて肌を十分に保湿することは、肌荒れ改善等に有効である。 For people with dryness sensitive skin that is easily affected by external irritation, dryness, etc., sufficiently moisturizing the skin using cosmetics or the like is effective in improving rough skin.
保湿のためには、肌からの水分の蒸散を抑制すること(角質水分蒸散量TEWLの減少)、及び肌自身に水分を保持させることが効果的である。 For moisturizing, it is effective to suppress the transpiration of moisture from the skin (decrease in the amount of horny moisture transpiration TEWL) and to retain moisture in the skin itself.
従来、保湿剤として、多価アルコール(例えば、1,3−ブチレングリコール、ジプロピレングリコール、グリセリン等)、アミノ酸またはその塩、糖鎖(例えば、キシリトール等)、ムコ多糖(例えば、ヒアルロン酸またはその塩等)、ガム類及びカルボキシビニルポリマー(アクリル酸/アクリル酸アルキル(C10−30)共重合体等の水溶性高分子、有機酸又はその塩、セラミド、動植物抽出物等のエキス類等が用いられている。 Conventionally, as a humectant, a polyhydric alcohol (for example, 1,3-butylene glycol, dipropylene glycol, glycerin, etc.), an amino acid or a salt thereof, a sugar chain (for example, xylitol, etc.), a mucopolysaccharide (for example, hyaluronic acid or a salt thereof) Salts, etc.), gums and carboxyvinyl polymers (acrylic acid / alkyl acrylate (C10-30) copolymers and other water-soluble polymers, organic acids or salts thereof, ceramides, extracts of animals and plants, etc.) It has been.
例えば、特許文献1には、アミノ酸を含有する皮膚化粧料が記載されている。
For example,
また、特許文献2には、セラミドを含有する皮膚外用剤が記載されている。 Patent Document 2 describes a skin external preparation containing ceramide.
しかし、従来の皮膚化粧料及び皮膚外用剤は、その水分保持効果及び水分蒸散抑制効果が不十分であり、高い水分保持効果及び水分蒸散抑制効果が得られる皮膚外用組成物の開発が切望されている。
本発明は、上記状況に鑑み、高い保湿力、すなわち水分保持効果及び水分蒸散抑制効果を示す皮膚外用組成物を提供することを課題とする。 In view of the above situation, an object of the present invention is to provide a composition for external use on skin, which exhibits high moisturizing power, that is, moisture retention effect and moisture transpiration suppression effect.
本発明者は、上記課題を解決すべく鋭意検討した結果、セラミドとアミノ酸とを特定の割合で含有する皮膚外用組成物が高い水分保持効果及び水分蒸散抑制効果を示し、従って、当該組成物を用いることによって高い保湿効果を得ることを見出した。本発明はかかる新規の知見に基づくものである。 As a result of intensive studies to solve the above problems, the present inventor showed that a composition for external use containing ceramide and an amino acid at a specific ratio showed a high moisture retention effect and a moisture transpiration suppression effect. It has been found that a high moisturizing effect can be obtained by use. The present invention is based on such novel findings.
従って、本発明は、以下の項に示す皮膚外用組成物に関する:
項1.組成物中に0.00022〜0.15重量%のセラミド及び0.0015〜0.75重量%のアミノ酸を含有し、かつセラミド1重量部に対して4重量部より多く且つ16重量部未満のアミノ酸を配合する皮膚外用組成物。
Accordingly, the present invention relates to a composition for external use for skin shown in the following section:
項2.セラミド1重量部に対して、5〜15重量部のアミノ酸を配合する、項1に記載の皮膚外用組成物。
Item 2. Item 5. The external composition for skin according to
項3.化粧料である、項1又は2に記載の皮膚外用組成物。
Item 3. Item 3. The external composition for skin according to
項4.前記セラミドが、セラミドI、セラミドII、セラミドIII及びセラミドVIからなる群より選択される少なくとも1種である、項1〜3のいずれか一項に記載の皮膚外用組成物。
Item 4. Item 4. The external composition for skin according to any one of
項5.前記アミノ酸が、セリン、グリシン、グルタミン酸、アラニン、リシン、アルギニン、トレオニン及びプロリンからなる群より選択される少なくとも1種である、項1〜4のいずれか一項に記載の皮膚外用組成物。
Item 5. Item 5. The external composition for skin according to any one of
本発明の皮膚外用組成物を用いることによって、高い保湿効果、すなわち水分保持効果及び水分蒸散抑制効果を得ることができる。また、本発明の皮膚外用組成物は、かかる保湿効果に加え、べたつきやきしみ感がなく、しっとりとした使用感を示すという利点も有する。 By using the external composition for skin of the present invention, a high moisturizing effect, that is, a moisture retention effect and a moisture transpiration suppression effect can be obtained. In addition to the moisturizing effect, the composition for external use of the present invention has an advantage that it has no stickiness or squeaky feeling and shows a moist feeling.
本発明組成物
本発明は、組成物中に0.00022〜0.15重量%のセラミド及び0.0015〜0.75重量%のアミノ酸を含有し、かつセラミド1重量部に対して4重量部より多く且つ16重量部未満のアミノ酸を配合する皮膚外用組成物を提供する。
Composition of the present invention The present invention comprises 0.00022 to 0.15% by weight of ceramide and 0.0015 to 0.75% by weight of amino acid in the composition, and 4 parts by weight with respect to 1 part by weight of ceramide. Provided is a composition for external use containing more and less than 16 parts by weight of an amino acid.
セラミド
本発明の皮膚外用組成物の有効成分であるセラミドは、スフィンゴシン又はフィトスフィンゴシン等のスフィンゴシンの類似塩基を中心の骨格とし、アミド結合により、OHをもたない脂肪酸、α−ヒドロキシ脂肪酸又はω−ヒドロキシ脂肪酸と結合している化合物である。
Ceramide, which is an active ingredient of the composition for external use of the skin of the present invention, is composed of a sphingosine or similar base of sphingosine such as phytosphingosine, a fatty acid having no OH by an amide bond, α-hydroxy fatty acid or ω- It is a compound that binds to hydroxy fatty acids.
セラミドとしては、例えば、天然又は天然型セラミドである(2S、3R)−セラミド1(以下、セラミドIと示す)、天然又は天然型セラミドである(2S、3R)−セラミド2(以下、セラミドIIと示す)、天然又は天然型セラミドである(2S、3R)−セラミド3(以下、セラミドIIIと示す)、天然又は天然型セラミドである(2S、3R)−セラミド4(以下、セラミドIVと示す)、天然又は天然型セラミドである(2S、3R)−セラミド5(以下、セラミドVと示す)、天然又は天然型セラミドである(2S、3R)−セラミド6(以下、セラミドVIと示す)等を挙げることができる。 Examples of the ceramide include (2S, 3R) -ceramide 1 (hereinafter referred to as ceramide I) which is natural or natural ceramide, and (2S, 3R) -ceramide 2 (hereinafter referred to as ceramide II) which is natural or natural ceramide. (2S, 3R) -ceramide 3 (hereinafter referred to as ceramide III), (2S, 3R) -ceramide 4 (hereinafter referred to as ceramide IV) which is a natural or natural ceramide. ), Natural or natural ceramide (2S, 3R) -ceramide 5 (hereinafter referred to as ceramide V), natural or natural ceramide (2S, 3R) -ceramide 6 (hereinafter referred to as ceramide VI), etc. Can be mentioned.
本発明においては、これらのセラミドのうち、好ましくはセラミドI、セラミドII、セラミドIII及びセラミドVIからなる群より選択される少なくとも1種であり、これら4種類のセラミドを全て配合するのがより好ましい。また、これら4種類のセラミドを組み合わせて用いる場合、総セラミド中、セラミドIは0.1〜30重量%が好ましく、0.2〜2.5重量%がより好ましく、0.2〜20重量%がさらに好ましく、セラミドIIは10〜80重量%が好ましく、10〜70重量%がより好ましく、20〜60重量%がさらに好ましく、セラミドIIIは5〜50重量%が好ましく、10〜45重量%がより好ましく、15〜45重量%がさらに好ましく、セラミドVIは5〜50重量%が好ましく、10〜45重量%がより好ましく、15〜45重量%がさらに好ましい。 In the present invention, among these ceramides, it is preferably at least one selected from the group consisting of ceramide I, ceramide II, ceramide III and ceramide VI, and it is more preferable to add all four of these ceramides. . When these four kinds of ceramides are used in combination, ceramide I in the total ceramide is preferably 0.1 to 30% by weight, more preferably 0.2 to 2.5% by weight, and 0.2 to 20% by weight. The ceramide II is preferably 10 to 80% by weight, more preferably 10 to 70% by weight, still more preferably 20 to 60% by weight, and the ceramide III is preferably 5 to 50% by weight and 10 to 45% by weight. More preferably, 15 to 45% by weight is further preferable, and ceramide VI is preferably 5 to 50% by weight, more preferably 10 to 45% by weight, and further preferably 15 to 45% by weight.
本発明の皮膚外用組成物は、これら各種セラミドを総量として好ましくは0.00022〜0.15重量%、より好ましくは0.0015〜0.12重量%含有する。 The skin external composition of the present invention preferably contains these various ceramides in a total amount of 0.00022 to 0.15% by weight, more preferably 0.0015 to 0.12% by weight.
本発明の組成物におけるセラミドの配合割合をこのような範囲とし、アミノ酸と併用することで角質水分保持率、角質水分蒸散抑制率などを効果的に向上させることができるため好ましい。 It is preferable to set the mixing ratio of ceramide in the composition of the present invention in such a range and use it together with an amino acid because the keratin moisture retention rate, the keratin moisture transpiration suppression rate and the like can be effectively improved.
また、本発明において、これらのセラミドには、その光学異性体も包含される。 In the present invention, these ceramides also include optical isomers thereof.
アミノ酸
本発明の皮膚外用組成物の有効成分である、アミノ酸は、分子内にカルボキシル基とアミノ基を有する化合物である。
Amino acid An amino acid, which is an active ingredient of the composition for external skin of the present invention, is a compound having a carboxyl group and an amino group in the molecule.
本発明においてアミノ酸とは、タンパク質を構成する主要アミノ酸を示し、グリシン、アラニン、バリン、ロイシン、イソロイシンに例示されるモノアミノモノカルボン酸;セリン、トレオニンに例示されるオキシアミノ酸;システイン、シスチン、メチオニンに例示される含硫アミノ酸;アスパラギン酸、グルタミン酸に例示されるモノアミノジカルボン酸(酸性アミノ酸);リシン、アルギニンに例示されるジアミノモノカルボン酸(塩基性アミノ酸)などの脂肪族アミノ酸(1);フェニルアラニン、チロシンに例示される芳香族アミノ酸(2);ヒスチジン(塩基性アミノ酸)、トリプトファン、プロリン、オキシプロリンに例示される複素環式アミノ酸(3)を挙げることができる。 In the present invention, an amino acid refers to a main amino acid constituting a protein, a monoamino monocarboxylic acid exemplified by glycine, alanine, valine, leucine and isoleucine; an oxyamino acid exemplified by serine and threonine; cysteine, cystine and methionine Sulfur-containing amino acids exemplified by: monoaminodicarboxylic acids (acidic amino acids) exemplified by aspartic acid and glutamic acid; aliphatic amino acids (1) such as diaminomonocarboxylic acids (basic amino acids) exemplified by lysine and arginine; Aromatic amino acids (2) exemplified by phenylalanine and tyrosine; heterocyclic amino acids (3) exemplified by histidine (basic amino acids), tryptophan, proline and oxyproline can be mentioned.
これらのアミノ酸は、ナトリウム塩、塩酸塩等の塩でもよい。これらのアミノ酸又はその塩は、単独又は2種以上を組み合わせて用いてもよい。本発明においては、セリン、グリシン、グルタミン酸、アラニン、リシン、アルギニン、トレオニン及びプロリンからなる群より選択される少なくとも一種のアミノ酸が好ましく、これら8種類のアミノ酸を組み合わせて用いるのがより好ましい。また、これら8種類のアミノ酸を組み合わせて用いる場合、総アミノ酸中、セリンは5〜60重量%が好ましく、10〜50重量%がより好ましく、20〜50重量%がさらに好ましく、グリシンは5〜50重量%が好ましく、5〜40重量%がより好ましく、10〜35重量%がさらに好ましく、グルタミン酸は5〜40重量%が好ましく、5〜30重量%がより好ましく、10〜30重量%がさらに好ましく、アラニンは1〜20重量%が好ましく、2〜15重量%がより好ましく、5〜15重量%がさらに好ましく、リシンは1〜20重量%が好ましく、2〜15重量%がより好ましく、5〜15重量%がさらに好ましく、アルギニンは0.5〜10重量%が好ましく、1〜8重量%がより好ましく、2〜8重量%がさらに好ましく、トレオニンは0.5〜10重量%が好ましく、1〜8重量%がより好ましく、2〜8重量%がさらに好ましく、プロリンは0.02〜8重量%が好ましく、0.05〜5重量%がより好ましく、0.1〜5重量%がさらに好ましい。 These amino acids may be salts such as sodium salt and hydrochloride. These amino acids or salts thereof may be used alone or in combination of two or more. In the present invention, at least one amino acid selected from the group consisting of serine, glycine, glutamic acid, alanine, lysine, arginine, threonine and proline is preferable, and it is more preferable to use these eight amino acids in combination. Moreover, when using these 8 types of amino acids in combination, serine is preferably 5 to 60% by weight, more preferably 10 to 50% by weight, even more preferably 20 to 50% by weight, and glycine is preferably 5 to 50% in the total amino acids. % By weight is preferred, 5 to 40% by weight is more preferred, 10 to 35% by weight is more preferred, glutamic acid is preferably 5 to 40% by weight, more preferably 5 to 30% by weight, and even more preferably 10 to 30% by weight. , Alanine is preferably 1 to 20% by weight, more preferably 2 to 15% by weight, further preferably 5 to 15% by weight, lysine is preferably 1 to 20% by weight, more preferably 2 to 15% by weight, 15 wt% is more preferable, arginine is preferably 0.5 to 10 wt%, more preferably 1 to 8 wt%, further preferably 2 to 8 wt%, The leonine is preferably 0.5 to 10% by weight, more preferably 1 to 8% by weight, further preferably 2 to 8% by weight, and the proline is preferably 0.02 to 8% by weight, and 0.05 to 5% by weight. More preferred is 0.1 to 5% by weight.
本発明の皮膚外用組成物は、これら各種アミノ酸を、総量として好ましくは0.0015〜0.75重量%、好ましくは0.0015〜0.7重量%含有する。 The external composition for skin of the present invention preferably contains these various amino acids in a total amount of 0.0015 to 0.75% by weight, preferably 0.0015 to 0.7% by weight.
本発明の組成物におけるアミノ酸の配合割合をこのような範囲とし、セラミドと併用することで角質水分保持率、角質水分蒸散抑制率などを効果的に向上させることができるため好ましい。 It is preferable that the mixing ratio of the amino acid in the composition of the present invention is in such a range and combined with ceramide can effectively improve the keratin moisture retention rate, the keratin moisture transpiration suppression rate, and the like.
また、本発明の皮膚外用組成物は、セラミド1重量部に対して、アミノ酸を4重量部より多く且つ16重量部未満、好ましくは、5〜15重量部、より好ましくは5〜8重量部、より好ましくは5〜7重量部、最も好ましくは6重量部含有することを特徴とする。 The composition for external use of the skin of the present invention is more than 4 parts by weight and less than 16 parts by weight, preferably 5 to 15 parts by weight, more preferably 5 to 8 parts by weight, based on 1 part by weight of ceramide. More preferably, it contains 5 to 7 parts by weight, most preferably 6 parts by weight.
本発明の皮膚外用組成物におけるセラミド及びアミノ酸の含有量は、上記の通りであるが、好ましい実施形態において、セラミドとアミノ酸との重量比、ならびにセラミド及びアミノ酸の含有量は、下記表1に示す実施形態1が好ましく、実施形態2がより好ましい。
The content of ceramide and amino acid in the external composition for skin of the present invention is as described above. In a preferred embodiment, the weight ratio of ceramide and amino acid, and the content of ceramide and amino acid are shown in Table 1 below.
また、より好ましい実施形態において、セラミドとアミノ酸との重量比、ならびにセラミド及びアミノ酸の含有量は、下記表2に示す実施形態3がさらに好ましく、実施形態4が最も好ましい。 In a more preferred embodiment, the weight ratio between ceramide and amino acid and the content of ceramide and amino acid are more preferably Embodiment 3 shown in Table 2 below, and most preferably Embodiment 4.
また、本発明の皮膚外用組成物におけるセラミドとアミノ酸の配合量は、前述のとおりであるが、セラミドとアミノ酸は、組成物中に総量で0.0017〜0.9重量%であることが好ましく、0.002〜0.8重量%であることがより好ましく、0.002〜0.6重量%であることがさらに好ましく、0.002〜0.4重量%であることがとくに好ましい。この範囲内であれば、角質水分保持率および単位量あたりの水分保持効果ならびに角質水分蒸散抑制率および単位量あたりの角質水分蒸散抑制効果をバランスよく向上させることができる。 Further, the blending amount of ceramide and amino acid in the external composition for skin of the present invention is as described above, but the total amount of ceramide and amino acid is preferably 0.0017 to 0.9% by weight in the composition. 0.002 to 0.8% by weight is more preferable, 0.002 to 0.6% by weight is further preferable, and 0.002 to 0.4% by weight is particularly preferable. Within this range, the stratum corneum moisture retention rate and the moisture retention effect per unit amount, the stratum corneum moisture transpiration suppression rate, and the stratum corneum moisture transpiration suppression effect per unit amount can be improved in a balanced manner.
本発明の皮膚外用組成物を用いれば、高い保湿効果、すなわち、以下の実施例において実証されるように、角質水分保持率および単位量あたりの水分保持効果ならびに角質水分蒸散抑制率および単位量あたりの角質水分蒸散抑制効果を満たすことができる。 When the composition for external use of the present invention is used, a high moisturizing effect, that is, a keratin moisture retention rate and a moisture retention effect per unit amount and a keratin moisture transpiration suppression rate and a unit amount as demonstrated in the following examples. It can satisfy the effect of suppressing keratin moisture transpiration.
具体的には、角質水分については、角質水分保持率が120%以上であり、好ましくは140%以上、より好ましくは300%以上であり、さらに好ましくは400%以上であり、とくに好ましくは500%以上である。上限はとくに限定されないが、通常1100%である。また、単位量あたりの水分保持効果が1000以上であり、好ましくは2000以上であり、より好ましくは3000以上である。上限はとくに限定されないが、通常110000以下である。 Specifically, for keratin water, the keratin water retention rate is 120% or more, preferably 140% or more, more preferably 300% or more, further preferably 400% or more, and particularly preferably 500%. That's it. The upper limit is not particularly limited, but is usually 1100%. Moreover, the moisture retention effect per unit amount is 1000 or more, preferably 2000 or more, and more preferably 3000 or more. Although an upper limit is not specifically limited, Usually, it is 110000 or less.
また、角質水分蒸散抑制については、角質水分蒸散抑制率が10%以上であり、好ましくは15%であり、より好ましくは20%であり、さらに好ましくは25%である。上限はとくに限定されないが、通常55%である。また、単位量あたりの水分蒸散抑制効果が50以上であり、好ましくは200以上であり、より好ましくは500以上であり、さらに好ましくは1000以上、とくに好ましくは2000以上である。上限はとくに限定されないが、通常6500以下である。 In addition, regarding the suppression of keratin moisture transpiration, the keratin moisture transpiration suppression rate is 10% or more, preferably 15%, more preferably 20%, and even more preferably 25%. The upper limit is not particularly limited, but is usually 55%. Moreover, the moisture transpiration suppression effect per unit amount is 50 or more, preferably 200 or more, more preferably 500 or more, still more preferably 1000 or more, and particularly preferably 2000 or more. Although an upper limit is not specifically limited, Usually, it is 6500 or less.
その他成分
本発明の皮膚外用組成物の基剤としては、例えば、水、ポリオール、アルコール、シリコーン油、炭化水素油、エステル油、植物油、高級アルコール、高級脂肪酸等を挙げることができる。
本発明の皮膚外用組成物は、上記セラミド、アミノ酸及び基剤に加えて、各用途に応じて、有効成分、及び添加剤を適宜含有してもよい。
Other components Examples of the base of the external composition for skin of the present invention include water, polyol, alcohol, silicone oil, hydrocarbon oil, ester oil, vegetable oil, higher alcohol, higher fatty acid and the like.
In addition to the ceramide, amino acid and base, the external composition for skin of the present invention may appropriately contain an active ingredient and an additive according to each application.
有効成分としては、例えば、紫外線防御剤、美白剤、抗炎症剤、抗老化剤、血行促進剤、香料、殺菌・消毒剤、制汗剤、消臭・防臭剤、育毛・養毛剤、除毛剤、染毛剤、パーマネントウェーブ剤、忌避剤、消炎鎮痛剤等を挙げることができる。 Examples of active ingredients include UV protection agents, whitening agents, anti-inflammatory agents, anti-aging agents, blood circulation promoters, fragrances, bactericides / disinfectants, antiperspirants, deodorants / deodorants, hair growth / hair restorers, hair removers , Hair dyes, permanent wave agents, repellents, anti-inflammatory analgesics and the like.
添加剤としては、例えば、ステロール、フッ素系油剤、界面活性剤、ヒドロキシ酸、グアニジン誘導体又はその塩、被膜形成性ポリマー、糖類、植物抽出物、抗酸化剤または一重項酸素消去剤、皮脂分泌抑制剤、ビタミン、ゲル化剤、粉体、無機塩、pH調整剤、粘度調整剤、酸化防止剤、防腐剤、金属イオン封鎖剤、冷感剤、色素、固形・半固形油、水溶性ポリマー、油溶性ポリマー、生体適合性ポリマー、リポソーム製剤、カプセル製剤、パール光沢付与剤、マイクロ・ナノエマルション製剤等を挙げることができる。 Examples of additives include sterols, fluorine-based oils, surfactants, hydroxy acids, guanidine derivatives or salts thereof, film-forming polymers, sugars, plant extracts, antioxidants or singlet oxygen scavengers, and sebum secretion suppression. Agent, vitamin, gelling agent, powder, inorganic salt, pH adjusting agent, viscosity adjusting agent, antioxidant, antiseptic, sequestering agent, cooling agent, pigment, solid / semi-solid oil, water-soluble polymer, Examples thereof include oil-soluble polymers, biocompatible polymers, liposome preparations, capsule preparations, pearlescent agents, and micro / nanoemulsion preparations.
本発明組成物の製造方法
本発明は、当該分野において通常用いられる方法により製造することができる。例えば、前述のセラミド及びアミノ酸、ならびに必要に応じてその他の成分を、セラミド及びアミノ酸の配合量が上記範囲となるように基剤に添加し、混合することにより製造することができる。
Production method of the composition of the present invention The present invention can be produced by a method usually used in the art. For example, it can be produced by adding the above-mentioned ceramide and amino acid and, if necessary, other components to the base so that the blending amount of ceramide and amino acid is in the above range and mixing them.
角質水分保持力および水分蒸散抑制力増強方法
セラミド及びアミノ酸を含有する組成物において、セラミド及びアミノ酸を上記範囲となるように含有させることによって、組成物における角質水分保持力および水分蒸散抑制力を一層増強させることができる。よって、本発明は、角質水分保持力および水分蒸散抑制力増強方法をも提供するものである。
Method for enhancing stratum corneum moisture retention and moisture transpiration suppression ability In a composition containing ceramide and amino acid, by adding ceramide and amino acid in the above range, the composition retains keratin moisture retention and moisture transpiration suppression. Can be enhanced. Therefore, the present invention also provides a method for enhancing keratin moisture retention ability and moisture transpiration inhibition ability.
本発明組成物の用途
本発明の皮膚外用組成物は、高い保湿効果、すなわち水分保持効果及び水分蒸散抑制効果を示すという利点を有する。
Use of composition of the present invention The composition for external use of the present invention has an advantage of exhibiting a high moisturizing effect, that is, a moisture retention effect and a moisture transpiration suppression effect.
従って、本発明の皮膚外用組成物は、皮膚に適用する化粧料、例えば、化粧石鹸、洗顔料、メイク落とし料、アイクリーム、アイシャドウ、クリーム、乳液、化粧水、香水、ファンデーション、おしろい、化粧油、練香水、パウダー、パック、日焼けオイル、日焼け止めオイル、日焼けローション、日焼け止めローション、日焼けクリーム、日焼け止めクリーム、ひげそり用クリーム、ひげそり用ローション、ほお紅、マスカラ、浴用化粧品、口紅、リップクリーム、アイライナー、デオドラント剤、入浴剤として用いることができる。 Therefore, the composition for external use of the skin of the present invention is a cosmetic applied to the skin, for example, cosmetic soap, facial cleanser, makeup remover, eye cream, eye shadow, cream, milky lotion, perfume, foundation, funnier, makeup Oil, perfume, powder, pack, tanning oil, sunscreen oil, tanning lotion, sunscreen lotion, tanning cream, sunscreen cream, shaving cream, shaving lotion, blusher, mascara, bath cosmetic, lipstick, lip balm, It can be used as an eyeliner, deodorant agent, bathing agent.
また、本発明の皮膚外用組成物は、皮膚に適用する化粧料だけでなく、毛髪用又は爪用の化粧料として用いることもできる。 Moreover, the composition for external use of the skin of the present invention can be used not only as a cosmetic applied to the skin but also as a cosmetic for hair or nails.
毛髪用化粧料としては、例えば、シャンプー、リンス、染毛料、養毛剤、育毛剤、眉墨等を挙げることができる。 Examples of hair cosmetics include shampoos, rinses, hair dyes, hair nourishing agents, hair restoring agents, eyebrows, and the like.
爪用化粧料としては、例えば、爪クリーム、美爪エナメル、美爪エナメル除去液等を挙げることができる。 Examples of nail cosmetics include nail cream, beautiful nail enamel, and beautiful nail enamel remover.
本発明の皮膚外用組成物は、化粧料用途以外にも、経皮医薬組成物等として用いることができる。 The external composition for skin of the present invention can be used as a transdermal pharmaceutical composition or the like in addition to cosmetic use.
経皮医薬組成物としては、例えば、殺菌消毒薬、しもやけ用薬、あかぎれ用薬、化膿性疾患用薬、外用鎮痛薬、外用鎮痒薬、外用収斂薬、外用消炎薬、みずむし・たむし用薬、皮膚軟化薬、毛髪用薬等を挙げることができる。 Examples of the transdermal pharmaceutical composition include bactericidal antiseptics, mosquitoes, redheads, purulent diseases, topical analgesics, topical antipruritics, topical astringents, topical antiphlogistics, wormworms, and insecticides. And emollients, hair drugs and the like.
本発明の皮膚外用組成物は、クリーム、軟膏、ローション、ジェル、液体等の形態をとり得る。 The external composition for skin of the present invention can take the form of cream, ointment, lotion, gel, liquid and the like.
以下に実施例を用いて本願発明の特定の形態について例示する。 Hereinafter, specific embodiments of the present invention will be illustrated using examples.
皮膚外用組成物の調製
成分A(セラミド)、成分B(アミノ酸)、成分C(乳化剤等)及び成分D(安定化剤等)を下記表3に従い、水に添加、混合し、実施例1〜84及び比較例1〜96の組成物を調製した。
Preparation of skin external composition Component A (ceramide), Component B (amino acid), Component C (emulsifier, etc.) and Component D (stabilizer, etc.) were added to water according to Table 3 below and mixed. 84 and compositions of Comparative Examples 1-96 were prepared.
このようにして調製した各実施例及び比較例毎に、以下の手順で角質水分量及び角質水分蒸散量を測定した。 For each of the Examples and Comparative Examples thus prepared, the amount of keratin water and the amount of horny water transpiration were measured by the following procedure.
角質水分量及び角質水分蒸散量の測定
試験室の外部環境を、室温20±1℃、湿度40±5%の一定条件に保った。
Measurement of horny water content and horny water transpiration The external environment of the test room was kept at a constant condition of room temperature 20 ± 1 ° C. and humidity 40 ± 5%.
まず、乾燥肌の被験者(n=10)を対象とし、5%ラウリル硫酸ナトリウム(SDS)水溶液を染み込ませたコットンを前腕内側部に貼付して1時間閉塞放置し、疑似的な荒れ肌を作り出した。 First, cotton skin soaked with 5% aqueous sodium lauryl sulfate (SDS) was applied to the inner side of the forearm and left blocked for 1 hour to create pseudo rough skin for subjects with dry skin (n = 10). .
コットンをはがし、コットン貼付部位を水洗した後、被験者を前記試験室へ入室させ、30分馴化後、5%SDS水溶液で処理した部位の角質水分量及び角質水分蒸散量を測定した(SDS処理後測定値)。 After the cotton was peeled off and the cotton sticking part was washed with water, the test subject was allowed to enter the test room, acclimated for 30 minutes, and the keratin water content and keratin water transpiration amount of the part treated with 5% SDS aqueous solution were measured (after SDS treatment). measured value).
5%SDS水溶液で処理した部位に比較例もしくは実施例の皮膚外用組成物または水(陰性比較対照)を30μl塗布し、塗布の1時間後に角質水分量及び角質水分蒸散量を測定した(試料塗布後測定値)。 30 μl of the composition for topical skin or water (negative comparison control) of Comparative Example or Example was applied to the site treated with 5% SDS aqueous solution, and the amount of horny water and the amount of horny water transpiration were measured 1 hour after application (sample application) After measurement).
なお、角質水分量は、SKICON−200(アイ・ビイ・エス株式会社製)を用い、角質水分蒸散量は、Tewameter(株式会社インテグラル製)を用いて、各機器のマニュアルに従い測定した(以下同様)。 In addition, the amount of keratin moisture was measured using SKICON-200 (made by IB S Co., Ltd.), and the amount of keratin moisture transpiration was measured according to the manual of each apparatus using Tewmeter (made by Integral Co., Ltd.) The same).
角質水分量保持率の算出
上記のように測定した、SDS処理後及び試料塗布後の角質水分量の測定値から、下記式に従い、角質水分量保持率を算出した。
Calculation of keratin moisture content retention rate The keratin moisture content retention rate was calculated according to the following formula from the measured value of the keratin moisture content after SDS treatment and sample application measured as described above.
角質水分量保持率=100×(試料塗布1時間後の水分保持量/SDS処理後の水分保持量)
単位量あたりの水分保持効果の算出
本発明組成物の水分保持効果を示すため、セラミドとアミノ酸との相乗効果を示す指標として、成分Aと成分Bの総量1重量%に換算した水分保持率(以下、単位量あたりの水分保持効果と示す)を算出した。具体的には、上記のように算出した角質水分量保持率及びA成分及びB成分の総濃度から、下記式に従い、単位量あたりの水分保持効果を算出した。
Keratin moisture retention rate = 100 × (moisture retention after 1 hour of sample application / moisture retention after SDS treatment)
Calculation of water retention effect per unit amount In order to show the water retention effect of the composition of the present invention, as an index showing the synergistic effect of ceramide and amino acid, the water retention rate converted to a total amount of 1% by weight of component A and component B ( Hereinafter, the moisture retention effect per unit amount was calculated. Specifically, the moisture retention effect per unit amount was calculated from the keratin moisture retention rate calculated as described above and the total concentrations of the A and B components according to the following formula.
単位量あたりの水分保持効果=角質水分量保持率/[成分A及び成分Bの総濃度(重量%)]
角質水分蒸散抑制率の算出
前述のように測定した、SDS処理後及び試料塗布後の角質水分蒸散量の測定値から、下記式に従い、角質水分蒸散抑制率を算出した。
Moisture retention effect per unit amount = stratum corneum moisture retention rate / [total concentration of component A and component B (% by weight)]
Calculation of stratum corneum moisture transpiration inhibition rate From the measured values of the amount of horny water transpiration after SDS treatment and sample application measured as described above, the stratum corneum moisture transpiration inhibition rate was calculated according to the following formula.
角質水分蒸散抑制率=100×(試料塗布1時間後の角質水分蒸散量−SDS処理後の試料塗布1時間後の角質水分蒸散量−角質水分蒸散量)/SDS処理後の角質水分蒸散量
単位量あたりの角質水分蒸散抑制効果の算出
本発明組成物の角質水分蒸散抑制効果を示すため、セラミドとアミノ酸との相乗効果を示す指標として、成分Aと成分Bの総量1重量%に換算した角質水分蒸散抑制効果(以下、単位量あたりの水分蒸散抑制効果と示す)を算出した。具体的には、上記のように算出した角質水分蒸散抑制率及び成分A及び成分Bの総濃度から、下記式に従い、単位量あたりの水分蒸散抑制効果を算出した。
Keratin moisture transpiration suppression rate = 100 × (Keratin moisture transpiration after 1 hour of sample application−Keratin moisture transpiration after 1 hour of sample application−Keratin moisture transpiration) / Keratin moisture transpiration after SDS treatment
Calculation of keratin moisture transpiration inhibiting effect per unit amount In order to show the keratin moisture transpiration inhibiting effect of the composition of the present invention, the total amount of component A and component B was converted to 1% by weight as an index showing the synergistic effect of ceramide and amino acid. The stratum corneum moisture transpiration inhibiting effect (hereinafter referred to as the moisture transpiration inhibiting effect per unit amount) was calculated. Specifically, the moisture transpiration suppression effect per unit amount was calculated from the keratin moisture transpiration suppression rate calculated as described above and the total concentrations of Component A and Component B according to the following formula.
単位量あたりの水分蒸散抑制効果=角質水分蒸散抑制率/[成分A及び成分Bの総濃度(重量%)]
各実施例及び比較例の角質水分量保持率、単位量あたりの水分保持効果、角質水分蒸散抑制率及び単位量あたりの角質水分蒸散抑制効果を表4〜16に示す。
Moisture transpiration control effect per unit amount = stratum corneum transpiration suppression rate / [total concentration of component A and component B (% by weight)]
Tables 4 to 16 show the keratin moisture retention rate, the moisture retention effect per unit amount, the keratin moisture transpiration suppression rate, and the keratin moisture transpiration suppression effect per unit amount of each Example and Comparative Example.
また、各実施例及び比較例の成分A(セラミド)含有量(横軸)および成分B(アミノ酸)の含有量(縦軸)を対数表示で図1に示す。さらに、成分A(セラミド)と成分B(アミノ酸)の総濃度(重量%)比について、関係式を直線式で例示した。 Moreover, the component A (ceramide) content (horizontal axis) and the content (vertical axis) of component B (amino acid) of each Example and Comparative Example are shown in logarithmic form in FIG. Furthermore, regarding the total concentration (% by weight) ratio of component A (ceramide) and component B (amino acid), the relational expressions are illustrated by linear expressions.
図1において、●は、実施例2、6、16、27、38、49、60、71および82をプロットしたものである。 In FIG. 1, ● represents a plot of Examples 2, 6, 16, 27, 38, 49, 60, 71 and 82.
図1において■は、実施例1、3、4、5、7、8、15、17、18、26、28、29、37、39、40、48、50、51、59、61、62、70、72、73、81、83および84をプロットしたものである。 In FIG. 1, ■ indicates Examples 1, 3, 4, 5, 7, 8, 15, 17, 18, 26, 28, 29, 37, 39, 40, 48, 50, 51, 59, 61, 62, 70, 72, 73, 81, 83 and 84 are plotted.
図1において◆は、実施例8〜14、19〜25、30〜36、41〜47、52〜58、63〜69および74〜80をプロットしたものである。 In FIG. 1, ♦ is a plot of Examples 8 to 14, 19 to 25, 30 to 36, 41 to 47, 52 to 58, 63 to 69, and 74 to 80.
図1において▲は、比較例をプロットしたものである。 In FIG. 1, ▲ is a plot of a comparative example.
また、表4〜16には記載していないが、A成分とB成分の配合比率が1:2以下のものを△で、またA成分とB成分の配合比率が1:30以上のものを×でプロットした。これらについては、角質水分量保持率、単位量あたりの水分保持効果、角質水分蒸散抑制率及び単位量あたりの角質水分蒸散抑制効果の点で比較例と同様の傾向であった。 Moreover, although not described in Tables 4-16, the thing with the compounding ratio of A component and B component being 1: 2 or less is (triangle | delta), and the compounding ratio of A component and B component is 1:30 or more. Plotted with ×. About these, it was the tendency similar to the comparative example at the point of the keratin moisture retention, the moisture retention effect per unit amount, the keratin moisture transpiration suppression rate, and the keratin moisture transpiration suppression effect per unit amount.
官能検査
各実施例及び比較例の各組成物について、それぞれ10名の前腕内側部に塗布し、使用感を下記5段階にて評価してもらった。得られた評価の平均を四捨五入し、5段階で「使用感評価」を算出した。官能検査の結果を表4〜16に示す。
Each composition of each sensory test example and comparative example was applied to the inner part of 10 forearms, and the usability was evaluated in the following 5 levels. The average of the obtained evaluations was rounded off, and “use feeling evaluation” was calculated in 5 stages. The results of the sensory test are shown in Tables 4-16.
(評価)
5 しっとりしており、ベタつきやきしみ感がない
4 しっとりしており、ベタつきやきしみ感がほとんどない
3 しっとりしているが、ややベタつきやきしみ感がある
2 しっとりしているが、ベタつきやきしみ感がある。
1 しっとり感がない
(Evaluation)
5 Moist and not sticky or squeaky 4 Moist and almost sticky or squeaky 3 Moist but slightly sticky or squeaky 2 Moist but sticky or squeaky There is.
1 There is no moist feeling
表4〜16及び図1に示されるように、組成物中に0.00022〜0.15重量%のセラミド及び0.0015〜0.75重量%のアミノ酸を有し、かつセラミド1重量部に対して4重量部より多く且つ16重量部未満のアミノ酸を配合する皮膚外用組成物は、角質水分量保持率、単位量あたりの水分保持効果、角質水分蒸散抑制率及び単位量あたりの角質水分蒸散抑制効果がいずれも高く、保湿効果に優れていた。 As shown in Tables 4 to 16 and FIG. 1, the composition has 0.00022 to 0.15% by weight of ceramide and 0.0015 to 0.75% by weight of amino acid, and 1 part by weight of ceramide. On the other hand, the composition for external use of skin containing more than 4 parts by weight and less than 16 parts by weight of amino acid has a keratin moisture retention rate, a moisture retention effect per unit amount, a keratin moisture transpiration suppression rate, and a keratin moisture transpiration per unit amount. The inhibitory effect was high and the moisturizing effect was excellent.
具体的には、組成物中のセラミドおよびアミノ酸の上記濃度範囲内において、例えば、比較例30(セラミド:アミノ酸=1:4)と実施例71(セラミド:アミノ酸=1:5)との比較、および比較例31(セラミド:アミノ酸=1:16)と実施例80(セラミド:アミノ酸=1:15)とを比較すると、セラミドとアミノ酸のそれぞれの配合量の違いは非常にわずかであるが、それらの配合割合を規定することで、非常に少量のセラミドおよびアミノ酸であっても、角質水分量保持率、単位量あたりの水分保持効果、角質水分蒸散抑制率および単位量あたりの水分蒸散抑制効果のすべてを向上でき、かつ使用感に優れていたことが分かる。 Specifically, within the above concentration range of ceramide and amino acid in the composition, for example, comparison between Comparative Example 30 (ceramide: amino acid = 1: 4) and Example 71 (ceramide: amino acid = 1: 5), When Comparative Example 31 (ceramide: amino acid = 1: 16) and Example 80 (ceramide: amino acid = 1: 15) were compared, the difference in the blending amount of ceramide and amino acid was very slight. By prescribing the blending ratio of keratin, even for very small amounts of ceramide and amino acids, the keratin moisture retention rate, moisture retention effect per unit amount, keratin moisture transpiration inhibition rate and moisture transpiration inhibition effect per unit amount It can be seen that everything could be improved and that the feeling of use was excellent.
また、図2および3に示したとおり、組成物中にセラミドを単独(アミノ酸を含まない)で0.5重量%配合したとき角質水分保持率が738%、1.0重量%配合したとき1010%であり、また、アミノ酸を単独(セラミドを含まない)で1.9重量%配合したとき738%、3.05重量%配合したとき1002%であったが、例えば、実施例60(0.0286重量%のセラミド、0.171重量%のアミノ酸)および実施例82(0.114重量%のセラミド、0.686重量%のアミノ酸)の結果から分かるように、セラミドおよびアミノ酸の配合割合を規定することで、組成物中の濃度が低濃度であっても、優れた角質水分保持効果が奏されたことが分かる。 As shown in FIGS. 2 and 3, when ceramide is added alone (not containing amino acids) in an amount of 0.5% by weight in the composition, the keratin moisture retention is 738%, and 1010 when 1.0% by weight is added. In addition, it was 738% when 1.9% by weight of an amino acid alone (ceramide was not included) and 1002% when 3.05% by weight was added. As can be seen from the results of 0286% by weight of ceramide, 0.171% by weight of amino acid) and Example 82 (0.114% by weight of ceramide, 0.686% by weight of amino acid), the mixing ratio of ceramide and amino acid is defined. Thus, it can be seen that even if the concentration in the composition was low, an excellent keratin moisture retention effect was achieved.
処方例
表17〜24に記載の処方にしたがって、定法どおり組成物を調製した。
Formulation Examples According to the formulations described in Tables 17 to 24, compositions were prepared as usual.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007159474A JP5455292B2 (en) | 2007-06-15 | 2007-06-15 | Skin external composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007159474A JP5455292B2 (en) | 2007-06-15 | 2007-06-15 | Skin external composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008308462A JP2008308462A (en) | 2008-12-25 |
JP5455292B2 true JP5455292B2 (en) | 2014-03-26 |
Family
ID=40236382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007159474A Active JP5455292B2 (en) | 2007-06-15 | 2007-06-15 | Skin external composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5455292B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8647649B2 (en) | 2009-07-06 | 2014-02-11 | Kao Corporation | Emulsified composition |
JP6212036B2 (en) * | 2012-05-11 | 2017-10-11 | 協和発酵バイオ株式会社 | Skin quality improver |
JP6356457B2 (en) * | 2014-03-28 | 2018-07-11 | 小林製薬株式会社 | Ceramide-containing external preparation composition |
JP6522908B2 (en) * | 2014-08-26 | 2019-05-29 | 小林製薬株式会社 | Composition for external use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3390868B2 (en) * | 2000-02-08 | 2003-03-31 | 株式会社ブルームフォーラム | Cosmetic and its use |
JP2002128653A (en) * | 2000-10-26 | 2002-05-09 | Kuorika Produce:Kk | Skin care preparation for preventing aging of skin |
JP4220698B2 (en) * | 2001-12-10 | 2009-02-04 | 花王株式会社 | Topical skin preparation |
JP2004168763A (en) * | 2002-10-30 | 2004-06-17 | Dsr Corp | Skin cosmetic |
JP2004238355A (en) * | 2003-02-07 | 2004-08-26 | Noevir Co Ltd | Liquid cosmetic |
JP4040527B2 (en) * | 2003-05-09 | 2008-01-30 | 高砂香料工業株式会社 | Lipid composition and external preparation for skin containing the same |
JP5112673B2 (en) * | 2006-10-16 | 2013-01-09 | 株式会社コーセー | Ceramide-containing composition and external preparation for skin containing the same |
-
2007
- 2007-06-15 JP JP2007159474A patent/JP5455292B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008308462A (en) | 2008-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20200074176A (en) | Cosmetic composition comprising nicotinamide mononucleotide | |
JPWO2004016236A1 (en) | Cosmetics | |
KR101453217B1 (en) | Cosmetics compositions for humectant | |
JP2011126879A (en) | Mild leave-on skin care composition | |
JP2012041302A (en) | Skin cosmetic | |
US20100166682A1 (en) | Chelated mineral water | |
JP2015500847A (en) | Moisturizing composition comprising aminopeptide mixture | |
KR20150066826A (en) | Cosmetics compositions for prevention and improvement of wrinkle | |
JP2000229834A (en) | Cosmetic | |
KR20090054777A (en) | Composition for controlling ph of skin and cosmetics comprising the same | |
JP5455292B2 (en) | Skin external composition | |
JP6356457B2 (en) | Ceramide-containing external preparation composition | |
JP2017193506A (en) | Skin Cosmetic | |
JP6052181B2 (en) | Cosmetics | |
WO2016033899A1 (en) | Dandruff removing composition for adjusting scalp oil balance | |
JP7256624B2 (en) | Gel-form external preparation for skin or skin cosmetics | |
JP2007031316A (en) | Anti-ultraviolet stimulating agent using anti-mutagenicity | |
JP2002275027A (en) | Cosmetic and cosmetic impregnated in nonwoven fabric | |
JP6486590B2 (en) | Anti-aging agent | |
KR20020088004A (en) | An toilet composition for protecting and combating blemishes and aging of the skin | |
JP2014169260A (en) | Cosmetic | |
McMullen | Maleic anhydride applications in personal care | |
FR2968952A1 (en) | N-ACYL AMINO ACID ESTER AS A SOOTHING AGENT | |
WO2017190035A1 (en) | Fragrance primer compositions and methods | |
KR101107312B1 (en) | A cosmetic composition for improving and caring skin comprising a peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100506 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121121 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130311 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131217 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140107 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5455292 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |